Ursodeoxycholic acid acts as an ileal FXR agonist in male mice with hepatic deficiency of FXR
{{output}}
Background: Farnesoid X receptor (FXR) has been identified as a therapeutic target for metabolic dysfunction-associated steatohepatitis (MASH). Hepatic FXR is especially critical in suppressing liver inflammation. FXR agonism and... ...
